China National Accord Medicines Corporation Ltd. (200028.SZ) SHZ

Currency In HKD

AD

Valuation

Market Cap10.63B
Enterprise Value17.49B
P/E Ratio10.67
PEG Ratio0.12
Price/Sales Ratio0.15
Price/Book Ratio0.61
Enterprise/Revenue0.26
Enterprise/EBITDA8.49

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.06

Income Statement

Revenue73.42B
Revenue/Share131.95
Gross Profit7.84B
EBITDA3.06B
Net Income1.11B
Diluted EPS1.03

Balance Sheet

Total Cash5.18B
Total Cash/Share9.37
Total Debt3.38B
Total Debt/Equity0.69
Current Ratio1.56
Book Value Per Share39.64

Price History

52-Week Change7.89
52-Week High12.81
52-Week Low11.5
Moving Average 50 Days12.09
Moving Average 200 Days12.4

Statistics

Average Volume170,816
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield2.93
Payout Ratio0.45
Last Split Factor11:10
Last Split DateJune 24, 2026
AD